Clinical significance of serum protease-activated receptor 1 (PAR1) level in patients with breast cancerRumeysa Ciftci a, Faruk Tas b, Elif Bilgin c, Serkan Keskin b, Ibrahim Yildiz b, Derya Duranyildiz c, Pınar Saip b, Hasan Karanlikd, Sezai Vatansever ba Bakirkoy Dr Sadi Konuk Education and Research Hospital, Medical Oncology Department, Istanbul, Turkey
b Istanbul University, Institute of Oncology, Medical Oncology Department Capa, Istanbul, Turkey
c Istanbul University, Institute of Oncology, Basic Oncology Department Capa, Istanbul, Turkey
d Istanbul University, Institute of Oncology, Surgical Oncology Unit, Capa, Istanbul, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.003 Pages: 7 - 11 1496 Viewed.
Adjuvant chemoradiotherapy combined with cisplatin, 5-fluorouracil and folinic acid for locally advanced gastric cancerMuharrem Kocar a, Ferhat Telli b, Berkant Sonmeza, Hande Kocar ca Department of Medical Oncology, Sanliurfa State Hospital, Sanliurfa, Turkey
b Department of Medical Oncology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
c Department of Radiation Oncology, Sanliurfa State Hospital, Sanliurfa, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.002 Pages: 12 - 15 1391 Viewed.
Electronic cigarette (e-cigarette)Erdinc Nayir a, Burak Karacabey b, Onder Kirca c, Mustafa Ozdogan ca Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, Turkey
b Akdeniz University Faculty of Medicine, Antalya, Turkey
c Department of Medical Oncology, Antalya Memorial Hospital, Antalya, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.001 Pages: 16 - 20 1609 Viewed.
A snapshot of residents in medical oncology in Turkey: A Nationwide survey on profile and key problemsErdinc Nayir a, Alper Ata b, Suleyman Erdogdu c, Tarik Salman d, Mehmet Ali Sungur e, Hüseyin Abalı f, Ali Arican fa Department of Medical Oncology, Kahramanmaras Necip Fazil City Hospital, Kahramanmaras, Turkey
b Department of Medical Oncology, Medical Park Tarsus Hospital, Mersin, Turkey
c Department of Medical Oncology, Elazig Training and Research Hospital, Elazig, Turkey
d Department of Medical Oncology, Yesilyurt State Hospital, _Izmir, Turkey
e Department of Biostatistics, Düzce University Faculty of Medicine, Düzce, Turkey
f Department of Medical Oncology, Acibadem University Faculty of Medicine, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.05.001 Pages: 21 - 24 1445 Viewed.
Endometrial carcinoma and paraneoplastic immune thrombocytopeniaHilmi Kodaz a, Muhammet Bekir Hacioglu b, Cagnur Elpen Kodaz b, Ahmet Cinkaya c, Bulent Erdogan a, Irfan Cicin aa Department of Medical Oncology, Faculty of Medicine, Trakya University, Turkey
b Public Health Agency of Edirne, Turkey
c Department of Radiation Oncology, Faculty of Medicine, Dumlupinar University, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.006 Pages: 25 - 26 1595 Viewed.
An unexpected cause of hyponatremia in a cancer patient: Trimethoprim-sulfamethoxazoleDilsa Mizrak a, Emra Asfuroglu Kalkan b, Ali Alkan a, Halis Yerlikaya a, Elif Berna Koksoy a, Ebru Karci a, Gungor Utkan a, Ahmet Demirkazik aa Ankara University, Department of Medical Oncology, Ankara, Turkey
b Ankara University, Department of Internal Medicine, Ankara, TurkeyDOI: https://doi.org/10.1016/j.jons.2016.04.005 Pages: 27 - 28 1693 Viewed.
Association between efficacy and skin rash following treatment with the lapatinib in metastatic breast cancerSuleyman Temiz a, Serap Kaya a, Gokhan Erbag b, Gorkem Aksu c, Kazım Uygun aa Kocaeli University, Medical Faculty, Deparment of Medical Oncology, Turkey
b Kocaeli University, Medical Faculty, Department of Internal Medicine, Turkey
c Kocaeli University, Medical Faculty, Deparment of Radiation Oncology, TurkeyDOI: http://dx.doi.org/10.1016/j.jons.2016.04.004 Pages: 29 - 31 1464 Viewed.